Regulatory cross-talk between drug metabolism and lipid homeostasis: constitutive androstane receptor and pregnane X receptor increase Insig-1 expression

Molecular Pharmacology
Adrian RothUrs A Meyer

Abstract

Activation of pregnane X receptor (PXR) and constitutive androstane receptor (CAR) by xenobiotic inducers of cytochromes P450 is part of a pleiotropic response that includes liver hypertrophy, tumor promotion, effects on lipid homeostasis, and energy metabolism. Here, we describe an acute response to CAR and PXR activators that is associated with induction of Insig-1, a protein with antilipogenic properties. We first observed that activation of CAR and PXR in mouse liver results in activation of Insig-1 along with reduced protein levels of the active form of sterol regulatory element binding protein 1 (Srebp-1). Studies in mice deficient in CAR and PXR revealed that the effect on triglycerides involves these two nuclear receptors. Finally, we identified a functional binding site for CAR and PXR in the Insig-1 gene by in vivo, in vitro, and in silico genomic analysis. Our experiments suggest that activation Insig-1 by drugs leads to reduced levels of active Srebp-1 and consequently to reduced target gene expression including the genes responsible for triglyceride synthesis. The reduction nuclear Srebp-1 by drugs is not observed when Insig-1 expression is repressed by small interfering RNA. In addition, observed that Insig-1 is a...Continue Reading

References

Sep 1, 1990·Archiv der Pharmazie·I H HallJ H Maguire
Sep 27, 2000·Proceedings of the National Academy of Sciences of the United States of America·C HandschinU A Meyer
Mar 15, 2001·Proceedings of the National Academy of Sciences of the United States of America·J L StaudingerS A Kliewer
Jun 5, 2002·The Journal of Biological Chemistry·Christoph HandschinUrs A Meyer
Sep 21, 2002·Proceedings of the National Academy of Sciences of the United States of America·Daisuke YabeJoseph L Goldstein
Mar 20, 2003·Proceedings of the National Academy of Sciences of the United States of America·Wendong HuangDavid D Moore
Dec 6, 2003·Pharmacological Reviews·Christoph Handschin, Urs A Meyer
Apr 21, 2004·Proceedings of the National Academy of Sciences of the United States of America·Kiyosumi TakaishiRoger H Unger
Jan 11, 2007·Proceedings of the National Academy of Sciences of the United States of America·Sharon M BlättlerUrs A Meyer

❮ Previous
Next ❯

Citations

Sep 15, 2012·Archives of Toxicology·Aneta DoricakovaZdenek Dvorak
Apr 8, 2010·Pharmaceutical Research·Subhajit Mukherjee, Sridhar Mani
Mar 5, 2010·Toxicological Sciences : an Official Journal of the Society of Toxicology·Doug CrumpSean W Kennedy
Aug 26, 2010·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Jie Gao, Wen Xie
Jun 21, 2011·Journal of Lipid Research·Yipeng SuiChangcheng Zhou
Mar 5, 2011·Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan·Yuichiro Kanno, Yoshio Inouye
May 14, 2010·Experimental Biology and Medicine·Maxwell Afari Gyamfi, Yu-Jui Yvonne Wan
Sep 11, 2009·PloS One·Britta BjörkholmSven Pettersson
Jul 14, 2012·Toxicological Sciences : an Official Journal of the Society of Toxicology·Jie ChengFrank J Gonzalez
Apr 19, 2011·Annual Review of Biochemistry·Joshua Wollam, Adam Antebi
May 13, 2014·Biochimica Et Biophysica Acta·Panagiota Karagianni, Iannis Talianidis
Oct 24, 2009·Proceedings of the National Academy of Sciences of the United States of America·Bingning DongDavid D Moore
May 17, 2015·Expert Opinion on Drug Metabolism & Toxicology·Milu T CherianTaosheng Chen
May 27, 2011·Drug Metabolism Reviews·Matthew D Merrell, Nathan J Cherrington
May 21, 2010·Drug Metabolism Reviews·Zdenek Dvorak, Peotr Pavek
May 25, 2013·Drug Metabolism Reviews·Susumu Kodama, Masahiko Negishi
Jan 19, 2013·Expert Opinion on Drug Metabolism & Toxicology·Xiaojuan ChaiWen Xie
Sep 15, 2012·Molecular and Cellular Endocrinology·Tingting ZhouYue Zhao
Aug 15, 2012·Trends in Pharmacological Sciences·Jie Gao, Wen Xie
Jun 6, 2012·Molecular and Cellular Endocrinology·Kondababu KurakulaCarlie J M de Vries
Jan 30, 2014·Protein & Cell·Hui Yang, Hongbing Wang
Sep 8, 2010·Peptides·Xiao-Ying Dong, Sheng-Qiu Tang
Jul 28, 2010·Advanced Drug Delivery Reviews·Lei XiaoYonggong Zhai
Jul 15, 2009·Trends in Endocrinology and Metabolism : TEM·Taira WadaWen Xie
Dec 22, 2011·Journal of Lipids·Jorge A López-VelázquezNahum Méndez-Sánchez
May 14, 2009·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Amélie MoreauJean-Marc Pascussi
Jul 15, 2015·Toxicological Sciences : an Official Journal of the Society of Toxicology·Xiao-Jie ZhangShu-Yun Zhang
May 27, 2014·Circulation Journal : Official Journal of the Japanese Circulation Society·Lei XiaoXiaoqin Luo
Jan 10, 2008·Annual Review of Cell and Developmental Biology·Axel Nohturfft, Shao Chong Zhang
Dec 17, 2014·Acta Pharmacologica Sinica·Jiong YanWen Xie
Jun 14, 2016·Expert Opinion on Drug Metabolism & Toxicology·Peter OladimejiTaosheng Chen
Oct 7, 2016·Acta Pharmaceutica Sinica. B·William D HedrichHongbing Wang

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.